A 
61.22
-0.13%
Close of 9 Nov 2026, in CHF
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$8.86bn
FY2016FY2025
Net income
$834.3m
FY2016FY2025
Free cash flow
$1.47bn
FY2016FY2025
Shareholders' equity
$17.90bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8.86bn | $8.05bn | $7.68bn | $7.08bn | $6.74bn | $5.55bn | $6.10bn | $5.91bn | $5.52bn | $5.36bn |
| Gross profit | $4.89bn | $4.48bn | $4.26bn | $3.86bn | $3.78bn | $2.39bn | $2.98bn | $2.59bn | $2.60bn | $2.53bn |
| Research and development | $842.9m | $711.9m | $698.1m | $570.5m | $684.3m | $546.9m | $533.1m | $477.1m | $474.6m | $405.5m |
| Operating income | $1.16bn | $1.15bn | $829.8m | $546.1m | $471.4m | −$415.3m | −$178.0m | −$237.3m | −$62.6m | $8.1m |
| Net income | $834.3m | $827.3m | $791.6m | $272.3m | $305.6m | −$431.5m | −$533.1m | −$256.0m | $208.1m | −$138.2m |
| Diluted earnings per share | 1.69 | 1.66 | 1.59 | 0.55 | 0.62 | -0.88 | -1.09 | -0.52 | 0.43 | -0.28 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $25.63bn | $24.66bn | $24.07bn | $23.74bn | $22.75bn | $22.43bn | $22.48bn | $22.19bn | $22.26bn | $22.54bn |
| Cash and short-term investments | $1.31bn | $1.49bn | $894.8m | $796.4m | $1.28bn | $1.28bn | $694.9m | $406.4m | $139.8m | $131.7m |
| Total liabilities | $7.73bn | $7.15bn | $7.31bn | $7.75bn | $7.11bn | $7.13bn | $6.79bn | $6.33bn | $3.54bn | $3.84bn |
| Debt | $5.24bn | $5.14bn | $5.13bn | $5.07bn | $4.48bn | $4.50bn | $3.80bn | $136.0m | $149.0m | $159.3m |
| Shareholders' equity | $17.90bn | $17.52bn | $16.76bn | $15.99bn | $15.65bn | $15.30bn | $15.69bn | $15.86bn | $18.72bn | $18.70bn |
| Shares outstanding | 492m | 498m | 496m | 492m | 494m | 492m | 488m | 488m | 489m | 489m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $1.93bn | $1.69bn | $1.13bn | $989.1m | $1.09bn | $668.9m | $747.7m | $926.5m | $989.9m | $1.01bn |
| Capital spending | −$462.3m | −$544.5m | −$691.6m | −$605.5m | −$959.0m | −$460.8m | −$549.4m | −$578.6m | −$403.1m | −$411.2m |
| Free cash flow | $1.47bn | $1.14bn | $436.4m | $383.6m | $134.1m | $208.1m | $198.3m | $347.8m | $586.8m | $600.6m |
| Dividends paid | −$141.3m | −$105.7m | −$94.3m | −$81.3m | −$43.9m | −$43.9m | −$43.9m | −$43.9m | — | — |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.25bn | $2.15bn | $2.23bn | $2.12bn | $2.11bn | $2.01bn | $2.03bn | $1.99bn |
| Gross profit | $1.34bn | $1.21bn | $1.24bn | $1.18bn | $1.13bn | $1.12bn | $1.13bn | $1.11bn |
| Operating income | $38.3m | $333.1m | $256.4m | $269.8m | $200.7m | $380.3m | $321.0m | $269.8m |
| Net income | — | $150.3m | $177.8m | $192.6m | $143.0m | $284.4m | $230.8m | $213.7m |
| Diluted earnings per share | — | 0.31 | 0.36 | 0.39 | 0.29 | 0.58 | 0.46 | 0.43 |
| Cash from operations | $410.0m | $332.0m | $537.0m | $567.0m | $410.0m | $312.0m | $373.0m | $607.0m |
| Capital spending | −$77.0m | −$110.0m | −$138.0m | −$130.0m | −$82.0m | −$86.0m | −$73.0m | −$145.0m |
| Free cash flow | $333.0m | $222.0m | $399.0m | $437.0m | $328.0m | $226.0m | $300.0m | $462.0m |
| Total assets | $25.34bn | $25.77bn | $25.63bn | $25.59bn | $25.51bn | $25.20bn | $24.66bn | $24.68bn |
| Cash and short-term investments | $1.19bn | $1.35bn | $1.31bn | $1.22bn | $1.14bn | $1.15bn | $1.49bn | $1.61bn |
| Debt | $530.5m | $3.91bn | $597.0m | $3.97bn | $3.91bn | $3.87bn | $3.83bn | $155.2m |
| Shareholders' equity | $17.60bn | $18.04bn | $17.90bn | $17.93bn | $17.97bn | $17.88bn | $17.52bn | $17.38bn |
Financial ratios
Data as of 20 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 55.2% | 55.6% | 55.5% | 54.5% | 56.1% | 43.0% |
| Operating margin | 13.1% | 14.3% | 10.8% | 7.7% | 7.0% | -7.5% |
| Net margin | 9.4% | 10.3% | 10.3% | 3.8% | 4.5% | -7.8% |
| Return on equity | 4.7% | 4.7% | 4.7% | 1.7% | 2.0% | -2.8% |
| Return on assets | 3.3% | 3.4% | 3.3% | 1.1% | 1.3% | -1.9% |
| Free cash flow yield | 11.2% | 10.3% | 8.4% | 7.4% | 9.5% | 5.3% |
| Revenue growth | 9.9% | 4.8% | 8.5% | 5.1% | 21.3% | -9.0% |
| Earnings growth | 0.8% | 4.5% | 190.7% | -10.9% | -170.8% | -19.1% |
| Current ratio | 2.12x | 2.77x | 2.28x | 1.90x | 2.18x | 2.21x |
| Debt to equity | 0.03x | 0.22x | 0.23x | 0.24x | 0.21x | 0.22x |
| Equity ratio | 69.8% | 71.0% | 69.6% | 67.4% | 68.8% | 68.2% |
| Interest coverage | 6.67x | 7.36x | 5.40x | 5.25x | 4.83x | -4.12x |
| R&D as a share of sales | 9.5% | 8.8% | 9.1% | 8.1% | 10.2% | 9.8% |
| Buybacks as a share of market value | 1.2% | -0.3% | -0.9% | 0.5% | -0.4% | -0.9% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 7.7% | 9.8% | 4.9% |
| Operating income | 28.5% | — | 11.9% |
| Net income | 45.3% | — | 12.8% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 55.4% | 55.2% | 53.8% | 51.1% |
| Operating margin | 13.6% | 11.6% | 8.5% | 5.0% |
| Net margin | 9.8% | 8.6% | 5.9% | 2.9% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Price to earnings | 46.5 | 51.2 | 48.9 | 0.1 |
| Price to sales | 4.4 | 5.3 | 5.0 | — |
Dividends and splits
Per share, in the currency the company pays
Paid for 5 years. Last went ex-dividend on 5 May 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Paid in the year | 0.28 | 0.28 | 0.48 | 0.21 | 0.20 | 0.10 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.